2373-23-1

Basic information

• Product Name: DIOCTYLSULPHOSUCCINATE
• Synonyms: DIOCTYLSULPHOSUCCINATE
• CAS NO: 2373-23-1
• Molecular Formula: C20H38 O7 S
• Molecular Weight: 422.58
• Mol File: 2373-23-1.mol
• Article Data: 3

Chemical Properties

• Boiling Point: °Cat760mmHg
• Flash Point: °C
• Appearance: /
• Density: 1.098g/cm³
• PKA: 0.09±0.50(Predicted)
• CAS DataBase Reference: DIOCTYLSULPHOSUCCINATE(CAS DataBase Reference)
• NIST Chemistry Reference: DIOCTYLSULPHOSUCCINATE(2373-23-1)
• EPA Substance Registry System: DIOCTYLSULPHOSUCCINATE(2373-23-1)

Safety Data

• Hazardous Substances Data: 2373-23-1(Hazardous Substances Data)

Usage

General Description

Dioctylsulphosuccinate is a chemical compound commonly used as a surfactant and emulsifier in a variety of industrial and consumer products. It is a synthetic substance derived from sucrose, sulfur, and octyl alcohol. Dioctylsulphosuccinate is often found in personal care products such as shampoos, soaps, and lotions, as well as in industrial applications such as metalworking fluids, dispersants, and emulsifiers. It is known for its ability to decrease the surface tension of liquids, making them easier to mix and disperse, as well as increasing the stability of emulsions. While generally considered to be safe for use, it is important to handle dioctylsulphosuccinate with care and follow proper safety precautions when working with this chemical.

Upstream product

• 1639-66-3 sodium dioctyl sulfosuccinate 
• 318-98-9 Inderal 
• 2915-53-9 dioctyl maleate 

Relevant articles and documents

FORMULATIONS OF PROPRANOLOL AND ANALOGS AS AN AMORPHOUS MELT OR IONIC LIQUID FOR TRANSDERMAL DRUG DELIVERY

Melts or ionic liquids containing amorphous propranolol, topical formulations and patches for transdermal drug delivery, and methods of making and using thereof are described herein. The melts or ionic liquids may be in a topical drug delivery formulation or patch to be applied to the skin. The drug delivery formulation or patch contains a sufficient amount of the amorphous propranolol to deliver a therapeutically effective amount of the amorphous propranolol to the patient in need of treatment, such as for the treatment or amelioration of infantile hemangioma. The formulations have a low viscosity and reduced skin irritation compared to the crystalline propranolol free base (PFB). The melts or ionic liquids can be formed by a salt metathesis reaction.

Novel sulphosuccinates and detergent compositions containing them

The invention provides novel dialkyl sulphosuccinates in which one alkyl group is C6 and the other is C8, both alkyl groups preferably being straight chain. The soluble salts of these materials are useful detergents, exhibiting outstandingly good foaming performance, and may be used, for example, in shampoos, fabric washing compositions and, in particular, manual dishwashing compositions.